Amiodarone Reduction in Coronary Heart Trial - ARCH

Description:

Amiodarone Reduction in Coronary Heart (ARCH) was a single-center, randomized, double-blinded trial designed to test whether low-dose intravenous (IV) amiodarone (1 g/day) would prevent atrial fibrillation and decrease hospital stay after open heart surgery compared with placebo.